Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03155724 · ClinicalTrials.gov registry record · NA
QP ExCELs: MultiPole Pacing (MPP) Sub-Study
A NA study, sponsored by Biotronik.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT03155724 is a NA study that has completed, run by Biotronik. The registered enrollment target is 53 participants.
The verdict
NCT03155724, a NA study, has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to demonstrate that the MPP feature is effective by converting a percentage of cardiac resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a single-arm, multi-center, prospective trial within the ongoing QP ExCELs study (NCT02290028).
Interventions
- DEVICE MultiPole Pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2017-05-19 |
| Est. Completion | 2020-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03155724
The ClinicalTrials.gov registry entry for NCT03155724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MultiPole Pacing is the first listed.
NCT03155724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03155724 about?
NCT03155724 is a clinical study titled "QP ExCELs: MultiPole Pacing (MPP) Sub-Study". The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to demonstrate that the MPP feature is effective by converting a percentage of cardiac resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a single-arm, multi-center, prospective trial wit...
What is the current status of trial NCT03155724?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2017-05-19. Estimated completion is 2020-01-23.
What interventions are being tested in trial NCT03155724?
The interventions under investigation include: MultiPole Pacing (DEVICE).
Who is sponsoring clinical trial NCT03155724?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.